These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 31820065)
1. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status. Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065 [TBL] [Abstract][Full Text] [Related]
2. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414 [TBL] [Abstract][Full Text] [Related]
3. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach. Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613 [TBL] [Abstract][Full Text] [Related]
4. Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI. Aliotta E; Nourzadeh H; Batchala PP; Schiff D; Lopes MB; Druzgal JT; Mukherjee S; Patel SH AJNR Am J Neuroradiol; 2019 Sep; 40(9):1458-1463. PubMed ID: 31413006 [TBL] [Abstract][Full Text] [Related]
5. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
6. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004 [TBL] [Abstract][Full Text] [Related]
7. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas. Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193 [TBL] [Abstract][Full Text] [Related]
8. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping. Gao A; Zhang H; Yan X; Wang S; Chen Q; Gao E; Qi J; Bai J; Zhang Y; Cheng J Radiology; 2022 Mar; 302(3):652-661. PubMed ID: 34874198 [TBL] [Abstract][Full Text] [Related]
10. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI. Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status. Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160 [TBL] [Abstract][Full Text] [Related]
13. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas. Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813 [TBL] [Abstract][Full Text] [Related]
14. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models. Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427 [TBL] [Abstract][Full Text] [Related]
15. Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach. Cao M; Suo S; Zhang X; Wang X; Xu J; Yang W; Zhou Y Biomed Res Int; 2021; 2021():1235314. PubMed ID: 33553421 [TBL] [Abstract][Full Text] [Related]
16. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas. Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515 [TBL] [Abstract][Full Text] [Related]
17. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794 [TBL] [Abstract][Full Text] [Related]
18. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas. Wu S; Meng J; Yu Q; Li P; Fu S J Cancer Res Clin Oncol; 2019 Mar; 145(3):543-550. PubMed ID: 30719536 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features. Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745 [TBL] [Abstract][Full Text] [Related]
20. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features. Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]